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Abstract
Background: The number of trained specialists world-wide is insufficient to serve all children with pediatric
rheumatologic disorders, even in the countries with robust medical resources. We evaluated the potential of
diagnostic decision support software (DDSS) to alleviate this shortage by assessing the ability of such software to
improve the diagnostic accuracy of non-specialists.
Methods: Using vignettes of actual clinical cases, clinician testers generated a differential diagnosis before and after
using diagnostic decision support software. The evaluation used the SimulConsult® DDSS tool, based on Bayesian
pattern matching with temporal onset of each finding in each disease. The tool covered 5405 diseases (averaging
22 findings per disease). Rheumatology content in the database was developed using both primary references and
textbooks. The frequency, timing, age of onset and age of disappearance of findings, as well as their incidence,
treatability, and heritability were taken into account in order to guide diagnostic decision making. These capabilities
allowed key information such as pertinent negatives and evolution over time to be used in the computations.
Efficacy was measured by comparing whether the correct condition was included in the differential diagnosis
generated by clinicians before using the software (“unaided”), versus after use of the DDSS (“aided”).
Results: The 26 clinicians demonstrated a significant reduction in diagnostic errors following introduction of the
software, from 28% errors while unaided to 15% using decision support (p < 0.0001). Improvement was greatest for
emergency medicine physicians (p = 0.013) and clinicians in practice for less than 10 years (p = 0.012). This error
reduction occurred despite the fact that testers employed an “open book” approach to generate their initial lists of
potential diagnoses, spending an average of 8.6 min using printed and electronic sources of medical information
before using the diagnostic software.
Conclusions: These findings suggest that decision support can reduce diagnostic errors and improve use of
relevant information by generalists. Such assistance could potentially help relieve the shortage of experts in
pediatric rheumatology and similarly underserved specialties by improving generalists’ ability to evaluate and
diagnose patients presenting with musculoskeletal complaints.
Trial registration: ClinicalTrials.gov ID: NCT02205086
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Background
Children with rheumatologic diseases face a serious
shortage of trained specialists. As of the end of 2015,
325 pediatric rheumatologists in the United States had
active board certification [1], well below even the most
conservative estimates of an optimal rheumatologic
work force [2]. The lack of access to pediatric rheuma-
tology care is exacerbated by the fact that many of
these specialists are not full-time clinicians. Further,
pediatric rheumatologists generally work at academic
medical centers in large urban areas; [3] as of 2015, 22
states had two or fewer pediatric rheumatologists and
eight had none at all. This results in severely restricted
geographical access to pediatric rheumatologists, with
an earlier study finding that 24% of children in the
United States lived more than 80 miles from a pediatric
rheumatologist [4].
The lack of subspecialty availability and its negative
impact on patient care are not limited to pediatric
rheumatology, nor is it unique to the United States. A
white paper by the World Forum on Rheumatic and
Musculoskeletal Diseases found that of 26 countries for
which data were available, only France, Uruguay, Australia
and the US had more than one rheumatologist per
100,000 people, many of whom had administrative or re-
search responsibilities that further limited their availability
to patients [5]. In sub-Saharan Africa, fewer than 20 rheu-
matologists are available to serve more than 800,000,000
people [6]. The shortage has been particularly acute for
children, with an inadequate number of pediatric rheuma-
tologists on all continents; as of 2011, only two pediatric
rheumatologists served all of Africa [7]. For many patients
with rheumatologic disorders, the only option is to be
treated by primary care providers, many of whom are
untrained in rheumatology [8].
Features of rheumatologic conditions may exacerbate
the lack of access to pediatric specialists. Signs and
symptoms are often not specific, resulting in gatekeepers
having difficulty identifying which patients to refer to
pediatric rheumatologists. The most common reasons
for pediatric rheumatology referrals are joint pain or
swelling, abnormal results on lab tests such as erythro-
cyte sedimentation rate (ESR) and anti-nuclear antibody
(ANA), and unexplained fevers, but these are often
caused by infectious, genetic or orthopedic conditions
[9]. The result is that conditions more appropriately
diagnosed and managed by other caregivers occupy
appointments that would otherwise be available for
children with actual rheumatologic conditions. Similarly,
inadequate numbers of specialty clinics within a reason-
able distance often force generalists to choose between a
closer or earlier evaluation by an adult rheumatologist
or non-rheumatology pediatric specialist and a later, less
accessible referral to a fully trained pediatric rheumatologist
[10]. Such delays in receiving optimal care from a qualified
expert often result in demonstrably worse outcomes
[11, 12], particularly in rapidly progressive conditions
such as Kawasaki disease [13].
Despite the fact that the inadequate number of
pediatric rheumatologists has been recognized for more
than a decade, various attempts to ameliorate the short-
age have been ineffective. In 2007, a total of 81 trainees
were enrolled in United States Pediatric Rheumatology
three-year sub-specialty training programs; in 2015 there
were 85 [1]. These numbers include foreign medical
graduates who plan to return to their native countries to
practice, yet even the total average number of fellows is
barely keeping pace with the rate at which pediatric
rheumatologists leave the work force due to retirement
and decreasing clinical responsibilities [14]. Alternative
approaches for increasing the availability of rheumatolo-
gist care for children, such as hiring nurse practitioners
and other physician extenders [15] or use of virtual
consultations using telemedicine [16] either have had
minimal impact or are of unproven quality.
Such concerns about the inadequacy of the pediatric
rheumatology workforce, mounting costs of diagnosis
[17] as well as the potential for diagnostic errors in
complex subspecialties like rheumatology [18], have
combined with rapid technological advances in data
processing, electronic health records [19] and genome-
phenome analysis [20] to rekindle interest in computer
assisted diagnosis. Ready access to diagnostic decision
software that allows generalists and specialists to
minimize referral and diagnostic problems would be an
important advance in patient care and resource utilization.
Evaluating such decision support tools, however, involves
a key challenge. Assessments are most easily done using
common diseases, for which many cases can be found, but
clinicians value decision support most when an unusual
or unfamiliar condition is being considered. To meet this
challenge, we and others have used case vignettes of real
patients and studied responses before and after introduc-
tion of decision support tools [21–23].
In this report we describe a decision support tool,
SimulConsult®, which uses a statistical pattern-matching
approach to inform diagnostic assessments. Its viewable
database consists of evidence-based information derived
from the medical literature and curated by experts.
As the first test of the usefulness of this diagnostic
tool we assessed its accuracy in supporting diagnosis
and workup by pediatric rheumatologists and non-
pediatric rheumatologists.
Methods
The SimulConsult® diagnostic decision support tool is
based on Bayesian pattern matching taking into account
the temporal pattern of each finding in each disease
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[23]. The SimulConsult® tool was first used to support
the diagnosis of genetic and neurologic conditions.
Coverage of rheumatologic diseases was then added to
the existing version of the software in a “curation”
process in which disease findings were recorded. For
each disease, the decision support software takes into
account the prevalence at different ages, variations
between genders, treatability, and family history. For
each finding in each disease, frequency, age of onset, and
age of disappearance (if applicable) are also incorporated.
This quantitation and granularity of information increases
the ability to use data in the diagnostic process, including
pertinent negative results, efficacy of treatment and tem-
poral evolution of diseases. In addition, this information
forms the basis for iterative diagnosis, whereby sugges-
tions of other clinical or laboratory findings likely to be
therapeutically useful and cost effective in distinguishing
between diagnoses are offered by the software [24]. Sug-
gestions offered by the software are prioritized according
to disease severity and actuity, the urgency to make a diag-
nosis and the potential benefits of treatment. The software
is available to medical professionals and their trainees for
free after a simple registration at www.simulconsult.com.
The curated information was entered by rheumatology
fellows and junior faculty members using textbook and
literature resources, and then edited by senior rheuma-
tologists. Curation of findings (signs, symptoms and lab
values) in rheumatologic conditions was reviewed for
completeness using a checklist of 46 core clinical
rheumatology findings developed as part of this effort.
At the time of the current study, the tool covered
5405 diseases including the previously curated neuro-
logic and genetic content as well as the newly added
rheumatologic diseases. An average of 22 findings per
disease are described.
Twenty-six testers were asked to evaluate eight case
vignettes of real patients with confirmed diagnoses (six
had pediatric rheumatologic diagnoses; two had other
conditions with some rheumatologic findings). The cases
were synopsized in vignettes by a senior pediatric
rheumatologist (RPS) and averaged 295 words. Of the 26
testers, 13 were “junior” clinicians in the final year of
training or first year after completing specialty or sub-
specialty training. The remaining 13 had been practicing
for at least 10 years (“senior”) (Table 1). Ten of the 26
testers were pediatric rheumatologists, nine were pediatric
emergency medicine physicians and seven were general
pediatricians. Of the 26 testers, 12 were male and 14 were
female. All testers completed all cases. None of those who
curated information or reviewed it served as testers.
After reading each vignette and before using the deci-
sion support software, testers could use other resources
such as books, papers and general web searches. After
using such resources, but before using the diagnostic
software, testers generated ranked “Baseline” lists of
likely diagnoses and preferred laboratory tests, imaging
studies, and consultations from lists of generally avail-
able resources. Each tester then used the decision
support software to reassess each vignette, and again
provided diagnosis and workup lists (“Intervention”).
Building on our earlier study [23], testers were allowed
to select from lists with specific diagnoses (e.g., juvenile
psoriatic arthritis) or tests (e.g., magnetic resonance
angiogram) as well as categories of diseases (e.g.,
arthritis) or bundles of tests with multiple possible find-
ings (imaging study). After finishing each case, testers
completed a questionnaire about the time used for re-
search and for entering findings. On the first and last
case, they also answered several open-ended questions
about the process. Identities of all testers were blinded
from curators who scored responses.
Information entered into the software was recorded as
present or absent, and if known, timing or onset, allow-
ing analysis of whether tester diagnostic errors resulted
from user-input errors.
In order to assess subjects’ performances, rank-
ordered lists of differential diagnoses and recommended
diagnostic studies were prepared by the expert who had
previously been involved in each case. These lists served
as the “gold standard” against which tester responses
were evaluated. All gold standard differential diagnoses
included the proven diagnosis as #1. Two key quality
measures of the diagnostic lists generated by study
subjects were calculated: errors (tester’s differential diag-
nosis lists that omitted the correct diagnosis) and rele-
vance (fraction of diagnoses in the tester’s differential
diagnosis that were also in the gold standard). Corre-
sponding measures were also calculated for workup.
The evaluation and analysis of making a diagnostic
error (the binary outcome in the study) from a statistical
perspective included generalized estimating equations or
a GEE approach to account for the eight case vignettes
confronted by each of the 26 testers before and after use
of the DDSS software tool in decision making. The
statistical analysis included the within-subject correl-
ation (since these are not independent) and used a bino-
mial distribution and a logistic regression model because
an error in diagnosis is a binary (yes or no) outcome
[25]. The Wald test distributed as a chi-squared statistic
was used to determine whether the software tool aided








Junior 3 5 5 13
Senior 4 4 5 13
TOTAL 7 9 10 26
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in the reduction of diagnostic errors as well as to com-
pare the outcome-based diagnostic performance accord-
ing to level of training and particular medical specialty.
Two-tailed p < 0.05 was considered statistically signifi-
cant. IBM/SPSS software version 21.0 was used for ana-
lysis of the data (IBM Corporation, Armonk, NY).
Results
Effect on diagnostic errors
The case vignettes were difficult enough that testers did
not include the correct diagnosis, or even its category, in
the differential diagnosis (“diagnostic error”) in 28% of
case testing instances before using the decision support
(“baseline”). This was despite the fact that they were
allowed to use other resources such as textbooks, articles
or Web searches. Results of all eight cases together
indicate a significant overall effect of the software in
reducing diagnostic errors from an average of 28 to
15% overall, a relative decrease of 45% (Fig. 1; Wald
test = 19.88, p < 0.0001). Junior clinicians benefitted more
than did senior clinicians (Wald test = 6.26, p = 0.012).
There was no significant difference between male and
female clinicians (Wald test = 1.07, p = 0.30).
Error reduction was significantly larger for emergency
medicine physicians as compared to generalists and
rheumatologists (Fig. 2; Wald test = 6.21, p = 0.013).
The number of conditions listed in the differential
diagnosis declined both when the tester’s diagnosis
was supported by the decision support (“unchanged
correct”, as assessed from the instances in which there
was no diagnostic error either at baseline or after the
intervention) as well as in cases where the response
shifted from diagnostic error to no error (“reduced
error”) (Table 2).
This decrease in listed diagnoses was due in part to
testers listing fewer irrelevant diagnoses after using the
diagnostic support software (Fig. 3). Diagnoses of senior
clinicians were more relevant than those of other groups
at baseline, with a higher fraction of testers’ diagnoses
correlating with the gold standard differential diagnoses,
but juniors were able to match seniors after using the
decision support. Baseline relevance and aided relevance
were highest for the pediatric rheumatologists. Relevance
improved for all three groups of specialists. With the as-
sistance of the DDSS, non-rheumatologists approached
the baseline performance of rheumatologists, but did
not match it, as assessed by diagnostic error and rele-
vance (Fig. 3, right).
Testers spent an average of 20 min per case (Table 3),
of which half was spent using the decision support.
Use of other reference sources while developing the
baseline differential diagnosis consumed an average of
8.6 min.
Analysis of diagnostic errors
In order to identify potential ways to improve the diag-
nostic support software, we made use of the Baseline
versus Intervention information for each testing instance
to examine cases in which testers changed to or from a
diagnostic error. In 33 instances, the tester changed
from error (diagnosis or category not in the gold stand-
ard list of diagnoses) to correct response after using the
software (Table 4; “Fixed errors”). In seven instances, the
tester changed from correct to error (“Added errors”). In
other instances, no change was made. Overall, improve-
ments were made in 83% of instances in which changes
were made, including 100% of changes made by rheuma-
tologists and by junior emergency medicine physicians.
Changes in diagnoses led to improvements in 91% of
changes made by junior clinicians, while senior clinicians
improved in 72% of changes.
The state of the software was recorded in each testing
instance, allowing analysis of findings input by the tes-
ters and diagnoses displayed. In the seven testing
instances with new errors, there were a variety of input
errors, including findings in the case entered without
onset ages, findings omitted entirely or interpreted in-
correctly; findings not representing information in the
vignette being entered; or diagnoses high in the soft-
ware’s differential diagnosis rejected by the tester.
Fig. 1 Diagnostic errors by seniority (All 26 testers, 8 cases each = 208 testing instances)
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Results varied by tester
For the 26 testers, baseline diagnostic errors clustered
around the mid-values (17/26 testers with 13%–38%
errors; Fig. 4). After using diagnostic software, diagnostic
errors clustered around a lower error rate (20/26 with
0%–13% errors). Two of the testers had a net increase in
errors (Fig. 4). These two testers out of 26, both senior
pediatricians, accounted for 29% of new errors (2 of 7),
and 40% of unchanged errors (10 of 25). None of their
changes led to improvements (0 of 2), whereas the
remaining 24 testers had 85% of changes leading to
improvement (33 of 38).
Results varied by case (Additional file 1)
In seven of eight cases, there was a reduction in overall
diagnostic errors after use of decision support. In one
case there was no change in total (Table 5). In six of
eight cases the average baseline error before decision
support was 15%, but in two cases the error rates be-
fore decision support were 58 and 73%. The overall
likelihood of improvement in situations in which the
tester made a change was 83%, however, in the two
cases with the most baseline errors, 95% of changes
resulted in improvement.
Similar analyses were done for workup lists, but no
significant changes were found.
Discussion
This study examined the effect of diagnostic decision
support starting from a baseline of a clinician’s know-
ledge and unlimited availability of information resources
such as books and web searches. The testers spent
almost as much time with outside medical resources
as they did using the decision support software (8.6
vs. 10.9 min), but the improvement in diagnostic ac-
curacy attributable to the software was nonetheless
highly significant.
In actual clinical practice, if generalists were able to
lower their diagnostic errors to such an extent, we would
expect that the utility of subspecialty referrals would
improve significantly. For example, a review of referrals
to the rheumatology clinic at Boston Children’s Hospital
suggests that at least 10% could have been avoided or
directed to more appropriate consultants with minimal
diagnostic support (unpublished data). Such a reduction
in sub-optimal referrals would meaningfully reduce
unnecessary capacity utilization and shorten wait times
for the limited number of available clinic appointments.
In this study, junior rheumatologists equipped with
decision support were able to rival the diagnostic accur-
acy of their unaided senior colleagues, an improvement
that could further extend the availability of pediatric
rheumatology consultations. However, not all clinicians
appeared to benefit, with two of the 26 testers, both
senior pediatricians, having none of their changes after
diagnostic software leading to improvements, versus
85% of changes leading to improvements for the other
24. Better understanding of the reasons that benefits of
using the software varied so widely between individuals
will be necessary to optimize the value of DDSS.
While medical decision support systems have been
anticipated since the earliest years of computers, mean-
ingful attempts to incorporate such tools in the practice
of medicine largely have been unsuccessful. Even as
computational power and software capabilities have in-
creased exponentially, progress in machine-assisted diag-
nosis has been far less impressive [26]. This is often
ascribed to difficulty developing heuristics of the human
diagnostic process [27]. In an attempt to overcome these
challenges, SimulConsult® diagnostic software incorpo-
rates such components as temporal evolution of signs,
Fig. 2 Diagnostic errors by specialty (208 discrete tests)
Table 2 Number of diseases in differential diagnosis: mean
(median)




Baseline 4.6 (4) 4.4 (4) 5.2 (5)
Post-intervention 3.5 (3) 3.4 (3) 4.2 (4)
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symptoms and diseases and use of pertinent negatives to
improve diagnostic decision making. It already forms the
basis of widely used support software adopted as a pri-
mary educational tool by the Child Neurology Society and
mentioned by the UK Health Departments as a means of
facilitating rapid diagnosis of rare diseases [28].
Rheumatology, however, poses different challenges than
previous areas in which SimulConsult® has been proven
useful (neurology, genetics and genome-phenome ana-
lysis). For example, rheumatologic diagnoses rest primarily
on precise recognition of physical findings, rather than
confirmatory serologic, genetic or imaging findings. In
order to adapt the strengths of SimulConsult® to these
aspects of rheumatologic decision making, the present
iteration of this software included an explicit review
of the curation using a rheumatology-specific set of
core clinical findings. While many rheumatologic and
non-rheumatologic findings were used in curation of
information for diagnostic assistance, this study added
a new step in which a core set of 46 rheumatologic
findings was explicitly reviewed in each rheumatologic
disease. Such an approach was recommended in our
previous study because the same set of findings could also
be used for initial entry of patient information [23]. This
study suggests that this approach is particularly practical
in rheumatology due to the relatively small number of
clinical findings, compared with the much larger numbers
in other areas such as dysmorphology [29]. However, the
crucial importance of correct recognition and recording of
physical exam and historical findings was beyond the
scope of this study. Rather than vignettes as were used in
this study, answering this question will require actual
patients being assessed in real time. Such an approach will
present its own challenges, including metrics to assess the
software’s utility when each case will be amenable to only
a single evaluation.
A similar curation of core rheumatologic laboratory or
imaging tests will be central to the next version of the
rheumatologic DDSS. In particular, it will be important
to specify findings on laboratory tests and imaging
studies in rheumatologic conditions as thoroughly as
rheumatologic diagnoses are now curated. This will both
improve the ability of the software to help optimize the
diagnostic work-up, as well as allow for quantification of
potential cost-savings attributable to more efficient diag-
nosis. Another need identified was to group clinical tests,
such as measurements of proteinuria and hematuria in a
urinalysis “bundle”. This approach was shown previously
to be important as a means of more closely approximating
the clinical utility of radiologic tests [23]. In addition, as
noted in the previous study, while diagnosis generally has
an objectively confirmed correct answer, there is often far
Fig. 3 Change in relevance of the diagnosis before and after decision support, by seniority and specialty
Table 3 Time spent using other resources and decision support by case (mean in minutes)
Case Case summary Before decision support While using decision support
1184 16 year-old boy with multiple joint pains 14.5 13.8
2088 17 year-old woman with rash, joint pain and swelling 7.8 10.9
3613 18 year-old woman with joint pain and fever 7.6 12.1
4967 8-year-old girl with rash and tenosynovitis 5.0 7.8
5615 10 year-old girl with elbow pain 6.5 8.9
6295 8 year old girl with rash, fevers and joint pain 9.7 11.5
7870 11 year-old boy with joint pain and fever 6.7 9.5
8434 18 year-old girl with joint pain, rash and fatigue 6.8 10.1
Average 8.6 10.9
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less agreement on prioritization of studies during the
diagnostic workup, with such vagaries evident even in
guidelines proposed by national governing bodies [30].
Even more than in neurologic and genetic disorders,
the time course of evolution of clinical findings plays a
major part in generating a differential diagnosis in
pediatric rheumatology. Most of the diseases evolve over
several weeks to years, as for example, scleroderma.
However, others evolve over a period of hours to days,
such as Henoch–Schönlein purpura, Kawasaki disease
and macrophage activation syndrome. Therefore, in car-
rying out this study we added a new type of finding to
represent acuity of onset of diseases. Although the tool
has a detailed model of onset ages and disappearance
ages for individual findings in each disease, there had
previously been no way of representing whether the
clinical manifestations of a disease emerge over minutes,
days or years. In this study, curation of such acuity infor-
mation was done for many conditions, but it was not
applied systematically to all possible diagnoses. Conse-
quently, although such acuity often did appear among
the findings suggested as useful, they could not be applied
routinely to diagnostic assessments since relevant data
were often missing, particularly for non-rheumatologic
mimics of rheumatologic conditions. Additional system-
atic curation of the range of onset acuities will improve
diagnostic accuracy, and augment the utility of the soft-
ware in settings in which temporal information is par-
ticularly important, such as emergency departments and
intensive care units.
One of the questions assessed in this study was whether
separate, disease-specific diagnostic tools are necessary for
different specialties. Eventually, in order to be useful in
emergency departments and primary care clinics, the
software will have to be able to distinguish joint pain and
swelling due to juvenile arthritis, mucopolysaccaridoses,
leukemia and Lyme disease. Part of the rationale of choos-
ing rheumatology for this study was its perceived low over-
lap with genetics and neurology information already in the
tool, allowing assessment of whether combining these
different areas was feasible. During this study it became
clear that the overlap with areas such as neuromuscular
neurology was greater than anticipated. This adds to our
assessment that separating coverage of these diseases into
different diagnostic tools might well be disadvantageous,
potentially contributing to balkanization of information and
increasing diagnostic errors due to “premature closure.”
This became apparent early in the study when the tool was
demonstrated to the pediatric rheumatology program at
Boston Children’s Hospital. A case that had been perceived
as diagnostically difficult within the department because
the diagnosis was outside of rheumatology actually con-
verged rapidly to a diagnosis once the findings were entered
into the diagnostic software tool.
Table 4 Changes by type of tester
Baseline errors Fixed errors Added errors Percent of changes that reduced errors
ALL
Rheumatologist 9 5 0 100%
Emergency 26 18 2 90%
Pediatrics 23 10 5 67%
Total 58 33 7 83%
JUNIORS
Rheumatologist 5 4 0 100%
Emergency 13 10 0 100%
Pediatrics 8 6 2 75%
Total 26 20 2 91%
SENIORS
Rheumatologist 4 1 0 100%
Emergency 13 8 2 80%
Pediatrics 15 4 3 57%
Total 32 13 5 72%
Fig. 4 Net diagnostic errors by tester
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In summary, our data suggest that SimulConsult® diag-
nostic software can be most useful in two situations: 1. To
help rheumatologists consider disorders typically outside of
rheumatology and 2. To help non-rheumatologists gen-
erate better-informed and timely referrals, thus improv-
ing utilization of scarce rheumatology expertise. Since
we saw examples of each of these phenomena in the
process of planning and carrying out this study, and the
results of the study confirmed significant diagnostic
benefit from the software for both rheumatologists and
non-rheumatologists, we conclude that the approach of
integrating diagnostic decision support for rheumatol-
ogy into clinicians’ workflow is practical and promising.
It seems likely that a single diagnostic support platform
may encompass many more medical specialties. One of
the initial benefits of such an approach will likely be
greater access to diagnostic expertise for underserved
specialties such as pediatric rheumatology,
In practice, such generalized diagnostic tools would
offer maximal utility for helping direct patients to appro-
priate specialists and appropriate centers of excellence.
In contrast, the alternative approach of having separate
diagnostic tools for different areas would only exacerbate
the tendency of organ system specific specialties to
function within non-communicating universes [31]. Al-
though extra effort will be necessary to construct tools
that integrate many disciplines, the advantages clearly
seem to warrant such an undertaking.
Conclusions
We assessed generalists’ and specialists’ ability to accur-
ately diagnose patients presenting with rheumatologic
signs and symptoms using actual case summaries. Tes-
ters were then allowed to reconsider their diagnoses
using the SimulConsult® tool. This diagnostic decision
software was originally created for use in neurology and
genetics, and for this study had been augmented with
information concerning rheumatologic conditions in
childhood. Diagnostic errors were decreased by 45%
overall, and among emergency medicine physicians by
62%. Pediatric rheumatologists’ ability to diagnose non-
rheumatologic mimics of rheumatologic diseases, such
as metabolic disorders, appeared to be improved as well.
We conclude that diagnostic decision software utilizing
novel pattern matching, taking into account the tem-
poral pattern of clinical findings, and incorporating a
multidisciplinary database holds promise as a means of
improving diagnosis of patients with rare diseases, par-
ticularly in underserved specialties such as pediatric
rheumatology.
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